We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Highly Sensitive Molecular Test Developed for Tuberculosis

By LabMedica International staff writers
Posted on 15 Sep 2014
Rapid, accurate detection of Mycobacterium tuberculosis is crucial in the diagnosis of tuberculosis (TB), but conventional diagnostic methods have limited sensitivity and specificity or are time consuming.

A new highly sensitive nucleic acid amplification (NAA) test, combined nested and real-time polymerase chain reaction (PCR) in a single tube, one-tube nested real-time PCR, was developed for detecting M. More...
tuberculosis, which takes advantages of two PCR techniques, including real-time PCR.

Biomedical Laboratory Scientists at Yonsei University (Wonju, Republic of Korea) and their colleagues collected sputum specimens from 167 subjects having active TB and from 108 healthy subjects. Sputum specimens were liquefied and processed and the sediment were suspended in sterile saline and used for smear preparation, inoculation into Löwenstein-Jensen (LJ) media and DNA extraction. The presence of acid fast bacilli (AFB) was examined using a light microscope and the results of AFB smear were graded.

Initial identification of M. tuberculosis was confirmed using the SD TB Ag MPT64 immunochromatographic test (SD Bioline Inc.; Yongin, Korea) and the REBA Myco-ID molecular diagnostic kit (M&D Inc.; Wonju, Korea). The scientists designed a one-tube nested real-time PCR to have two sequential reactions with two sets of primers and dual probes for the IS6110 sequence of M. tuberculosis in a single closed tube. A real-time PCR assays were performed and validated using an Applied Biosystems 7500 Fast Real-time PCR System (Foster City, CA, USA).

The minimum limits of detection of IS6110 real-time PCR was 100 fg/μL and for the IS6110 one-tube nested real-time PCR it was 1 fg/μL of M. tuberculosis DNA. AdvanSure TB/NTM real-time PCR (LG Life Science; Seoul, Korea), IS6110 real-time PCR, and one-tube nested real-time PCR showed 100% sensitivity and 100% specificity for clinical M. tuberculosis isolates and nontuberculous mycobacteria (NTM) isolates. In comparison, the sensitivities of AdvanSure TB/NTM real-time PCR was 91% (152/167), 94.6% (158/167) for the single IS6110 real-time PCR, and 100% (167/167) one-tube nested real-time PCR.

The authors concluded that the new efficient, highly sensitive PCR assay, one-tube nested real-time PCR targeting IS6110 sequence that was developed for detecting M. tuberculosis, utilizes the advantages of nested PCR and real-time PCR. One-tube nested real-time PCR showed superior sensitivity to conventional real-time PCR and AdvanSure TB/NTM real-time PCR, a commercial TB real-time PCR kit. The study was published on August 30, 2014, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Yonsei University 
SD Bioline Inc.
M&D Inc.




New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Serological Pipet Controller
PIPETBOY GENIUS
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.